Danielle Pearson - FDA Investigator Report
Designation: NURSE CONSULTANT
Duty Station: Silver Spring MD 20993-0002
Organizations: DHHS FDA CDER OMPT CDER OC OSI DEPS PSB
Overview Statistics
2
Total Inspections
0
Total 483s Issued
0
Warning Letters Issued
Inspection Details
Longest Inspection: 3 days
Shortest Inspection: 2 days
Average Length: 2.5 days
Discover the bigger picture. This is just the tip of the iceberg.
Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.
Schedule a DemoDanielle Pearson's Recent Inspections
| Date | Company | City | Country | FEI Number | 483 |
|---|---|---|---|---|---|
| 2018-11-14 | Otsuka Pharmaceutical Development & Commercialization, Inc | Rockville | United States | 3000718406 | |
| 2016-08-10 | Genzyme Corporation | Cambridge | United States | 1221955 |
Sign Up to get the complete report.
Download 483s and EIRs for Danielle PearsonDanielle Pearson - Co-Inspectors
| Name | Inspections | Last Inspection |
|---|---|---|
| John Dan | 1 | 2018 |
| John P Mistler | 1 | 2016 |
Danielle Pearson's Active Locations
- United States
Danielle Pearson's Year-wise Inspection Count
- 2016:1 inspections
- 2018:1 inspections
Last Updated: 2025-05-14 06:11:22